Author(s):
Sasikala M, Mohan S, Gokilambal V, Mymoona S, Hari P
Email(s):
sasikalampharm@gmail.com
DOI:
10.5958/0974-360X.2020.00764.7
Address:
Sasikala M1,2*, Mohan S1, Gokilambal V1, Mymoona S1, Hari P1
1Karpagam College of Pharmacy, Coimbatore - 641032, Tamil Nadu, India.
2Faculty of Pharmacy, Karpagam Academy of Higher Education, Karpagam University, Coimbatore - 641021, Tamil Nadu, India.
*Corresponding Author
Published In:
Volume - 13,
Issue - 9,
Year - 2020
ABSTRACT:
Aim and objective: To develop and validate a simple accurate and precise UV-spectrophotometric method to determine the degradation pathway of Oseltamivir in bulk form. Methodology: Separation of the drug from its degradation product was achieved by UV and scanned between 200-400nm. Oseltamivir was subjected to stress condition such as acid hydrolysis, alkali hydrolysis, oxidation, photolysis and thermal degradation. The samples were analyzed. Results: The maximum absorbance was found at 216nm and found to be linear over the range of 5-30µg/ml with good correlation co-efficient 0.999. Major degradation was observed in photolysis, oxidative and alkali degradation. Conclusion: The UV spectrophotometric method for Oseltamivir in the bulk form was developed and validated.
Cite this article:
Sasikala M, Mohan S, Gokilambal V, Mymoona S, Hari P. Validated UV-Visible Spectroscopic Analytical method development and stability studies on Oseltamivir. Research J. Pharm. and Tech 2020; 13(9):4323-4328. doi: 10.5958/0974-360X.2020.00764.7
Cite(Electronic):
Sasikala M, Mohan S, Gokilambal V, Mymoona S, Hari P. Validated UV-Visible Spectroscopic Analytical method development and stability studies on Oseltamivir. Research J. Pharm. and Tech 2020; 13(9):4323-4328. doi: 10.5958/0974-360X.2020.00764.7 Available on: https://rjptonline.org/AbstractView.aspx?PID=2020-13-9-52
REFERENCES:
1. Jagarlapudi Venkala Shathukha Kumar et.al; Application of potassium permanganate to the Spectrophotometric Determination of Oseltamivir in bulk and capsules,Asian Journal of Pharmaceutical and Clinical Research, 2012;5(2): 18-22.
2. A.Bunaciu et.al; A Fourier Transform Infra Red Spectrophotometry method used for Oseltamivir determination in Pharmaceutical formulations, Gazi University, Journal of Science, 2012; 25(3): 631-634.
3. Ajay Gupta et.al; Simultaneous quantification of prodrug Oseltamivir and its metabolite Oseltamivir carboxylate in human plasma by LC-MS/MS to support a bioequivalence study, Journal of Pharmaceutical Analysis, 2013; 3(3): 149-160.
4. Bjorn J. A Brendsen. Robin. S. et.al; Quantitative trace analysis of a broad range of antiviral drug in poultry muscle using Column-Switch Liquid Chromatography coupled to tandem Mass Spectroscopy, Anal-Bioanalytical chemistry, 2012; 402; 1611-1623.
5. M. Espinosa Bosch et.al; Analytical methodologies for the determination of Oseltamivir, Research Journal of Pharmaceutical, Biological and Chemical Sciences, 2010; 1(3): 368-376.
6. Michael D. Green et.al; Determination of Oseltamivir quality by Colorimetric and Liquid Chromatographic Methods, Research, 2018; 14(4): 552-556.
7. Rasha M. Youssef et.al; Validated Spectrophotometric methods for the evaluation of Oseltamivir counterfit Pharmaceutical Capsules, bulletein of faculty of pharmacy, Cario University,2014; 52: 63-69.
8. Ashish A.Thatte et.al; Development, Validation and application of UV Spectrophotometric methods for the determination of Oseltamivir phosphate in Bulk and Pharmaceutical Dosage Forms, International Journal of Chem Tech Research, 2011; 3(2): 569-573.
9. C. S. Raut et.al; Development and Validation of Oseltamivir phosphate in Fluvir® by UV Spectrophotometer, IJPRIF, 2010; 2(1): 363-366.
10. Charushila H. Bhirud et.al; Development and Validation of stability indicating HPTLC method for the determination of Oseltamivir phosphate in bulk and Pharmaceutical Dosage Form,IJPPR, 2017; 9(4): 299-311.
11. Panchumarthy Ravisankar et.al; Development and Validation of Stability indicating UV Spectrophotometric method for determination of Apremilast in Bulk And Pharmaceutical Dosage Form, International Journal of Research In Pharmacy And Biotechnology, 2017; 5(1): 47-53.
12. Sowmyalakshmi Venkatraman et.al; Forced degradation studies: Regulatory guidelines, Characterization of drugs and their degradation products-a review, drug invention today, 2018; 10(2): 137-146.
13. ICH Q1B Guidelines Photostability Testing of new drug substances and products, ICH Q1B, page no. 32-39.